Myocardial extracellular volume assessment at CT in hospitalized COVID-19 patients with regards to pulmonary embolism
暂无分享,去创建一个
F. Sardanelli | F. Secchi | M. Zanardo | D. Capra | G. Folco | Caterina Beatrice Monti | Francesco Silletta
[1] Yuchuan Wang,et al. Why Omicron Variant of SARS‐CoV‐2 is Less Fatal? , 2022, Chembiochem : a European journal of chemical biology.
[2] A. Sinusas,et al. Novel Cardiac Computed Tomography Methods for the Assessment of Anthracycline Induced Cardiotoxicity , 2022, Frontiers in Cardiovascular Medicine.
[3] W. Auffermann,et al. Incidence of pulmonary embolism in COVID-19 infection in the ED: ancestral, Delta, Omicron variants and vaccines , 2022, Emergency Radiology.
[4] V. Novakovic,et al. Long COVID: The Nature of Thrombotic Sequelae Determines the Necessity of Early Anticoagulation , 2022, Frontiers in Cellular and Infection Microbiology.
[5] Matthew W. Martinez,et al. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play , 2022, Journal of the American College of Cardiology.
[6] B. Cowling,et al. Omicron severity: milder but not mild , 2022, The Lancet.
[7] O. Geier,et al. Association between myocardial fibrosis, as assessed with cardiac magnetic resonance T1 mapping, and persistent dyspnea after pulmonary embolism , 2021, International journal of cardiology. Heart & vasculature.
[8] M. V. Van Kerkhove. COVID-19 in 2022: controlling the pandemic is within our grasp , 2021, Nature Medicine.
[9] E. Poveda,et al. Long COVID in hospitalized and non-hospitalized patients in a large cohort in Northwest Spain, a prospective cohort study , 2021, Scientific Reports.
[10] Cheuk-Kwan Sun,et al. Mortality and risk factors associated with pulmonary embolism in coronavirus disease 2019 patients: a systematic review and meta-analysis , 2021, Scientific Reports.
[11] Ari I. Jonisch,et al. Pulmonary Embolism in Hospitalized Patients with COVID-19: A Multicenter Study , 2021, Radiology.
[12] A. Mebazaa,et al. Pulmonary embolism in patients with COVID-19: incidence, risk factors, clinical characteristics, and outcome , 2021, European heart journal.
[13] H. Yabuuchi,et al. Right Ventricular Extracellular Volume with Dual-Layer Spectral Detector CT: Value in Chronic Thromboembolic Pulmonary Hypertension. , 2021, Radiology.
[14] D. Gopalan,et al. Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19 , 2020, The Lancet Respiratory Medicine.
[15] A. Sironi,et al. Computed tomography-derived myocardial extracellular volume: an early biomarker of cardiotoxicity in esophageal cancer patients undergoing radiation therapy , 2020, Insights into Imaging.
[16] A. Pollard,et al. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 , 2020, The Lancet Infectious Diseases.
[17] T. Kwee,et al. Chest CT in COVID-19: What the Radiologist Needs to Know , 2020, Radiographics : a review publication of the Radiological Society of North America, Inc.
[18] P. Angchaisuksiri,et al. Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis , 2020, Thrombosis Journal.
[19] Amit Kj Mandal,et al. Pulmonary embolism in COVID-19: Clinical characteristics and cardiac implications , 2020, The American Journal of Emergency Medicine.
[20] P. Kellman,et al. Females have higher myocardial perfusion, blood volume and extracellular volume compared to males – an adenosine stress cardiovascular magnetic resonance study , 2020, Scientific Reports.
[21] F. Sardanelli,et al. Assessment of myocardial extracellular volume on body computed tomography in breast cancer patients treated with anthracyclines. , 2020, Quantitative imaging in medicine and surgery.
[22] Francesco Sardanelli,et al. Statistical significance: p value, 0.05 threshold, and applications to radiomics—reasons for a conservative approach , 2020, European Radiology Experimental.
[23] M. Arrigo,et al. Pulmonary Embolism and Heart Failure: A Reappraisal , 2020, Cardiac failure review.
[24] A. Hamdy,et al. Feasibility of extracellular volume fraction calculation using myocardial CT delayed enhancement with low contrast media administration. , 2020, Journal of cardiovascular computed tomography.
[25] F. Sardanelli,et al. Point estimate and reference normality interval of MRI-derived myocardial extracellular volume in healthy subjects: a systematic review and meta-analysis , 2019, European Radiology.
[26] R. Perez-Johnston,et al. Pathophysiology of right ventricular failure in acute pulmonary embolism and chronic thromboembolic pulmonary hypertension: a pictorial essay for the interventional radiologist , 2019, Insights into Imaging.
[27] Richard B. Thompson,et al. Myocardial native T1 and extracellular volume with healthy ageing and gender , 2018, European heart journal cardiovascular Imaging.
[28] G. Krombach,et al. Native T1 mapping and extracellular volume fraction measurement for assessment of right ventricular insertion point and septal fibrosis in chronic thromboembolic pulmonary hypertension , 2017, European Radiology.
[29] S. Plein,et al. Cardiac T1 Mapping and Extracellular Volume (ECV) in clinical practice: a comprehensive review , 2016, Journal of Cardiovascular Magnetic Resonance.
[30] R. Wachter,et al. Late outcomes after acute pulmonary embolism: rationale and design of FOCUS, a prospective observational multicenter cohort study , 2016, Journal of Thrombosis and Thrombolysis.
[31] F. Sardanelli,et al. Novel cardiac magnetic resonance biomarkers: native T1 and extracellular volume myocardial mapping. , 2016, European heart journal supplements : journal of the European Society of Cardiology.
[32] P. Kellman,et al. Myocardial Fibrosis Quantified by Extracellular Volume Is Associated With Subsequent Hospitalization for Heart Failure, Death, or Both Across the Spectrum of Ejection Fraction and Heart Failure Stage , 2015, Journal of the American Heart Association.
[33] S. Punwani,et al. Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis , 2015, Journal of cardiovascular computed tomography.
[34] G. Korosoglou,et al. T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. , 2015, European heart journal cardiovascular Imaging.
[35] Stuart A. Taylor,et al. Measurement of myocardial extracellular volume fraction by using equilibrium contrast-enhanced CT: validation against histologic findings. , 2013, Radiology.
[36] Brian A. Nosek,et al. Power failure: why small sample size undermines the reliability of neuroscience , 2013, Nature Reviews Neuroscience.
[37] Jianhua Yao,et al. Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT. , 2012, Radiology.
[38] J. Kline,et al. Right ventricular heart failure from pulmonary embolism: key distinctions from chronic pulmonary hypertension. , 2010, Journal of cardiac failure.
[39] J. Evans. Straightforward Statistics for the Behavioral Sciences , 1995 .